Related Experiment Video
Updated: Feb 7, 2026

Lipidomics and Transcriptomics in Neurological Diseases
Published on: March 18, 2022
Onconeural antigen spreading in paraneoplastic neurological disease due to small cell lung cancer
Andre Dik1, Christine Strippel1, Constanze Mönig1
1Department of Neurology, University of Münster, Albert-Schweitzer-Campus 1, Münster, Germany.
Abstract:
Cellular and humoral immunity towards distinct onconeural antigens is the hallmark of paraneoplastic neurological diseases (PNDs). Stable formation of immunoglobulin (Ig) G antibodies to particular onconeural antigens occurs in the majority of cases, whereas persistent coexistence of antibodies specific for multiple onconeural antigens is a relatively rare phenomenon of certain malignant tumors like small cell lung cancer (SCLC). We here describe onconeural antigen spreading in a 70-year-old Caucasian male with PND due to SCLC. Onconeural antigen spreading may be promoted by two mutually non-exclusive mechanisms: (i) a switch of antigen expression pattern of the underlying tumor tissue as a result of a mutagenic process caused by the cancer itself and (ii) a self-propagated paraneoplastic immune response with persistent neuronal destruction, liberation, processing and presentation of intracellular neural antigens. This illustrates a potential dissociation between peripheral anti-tumoral immunity and central anti-neural immunity during the course of PND.
Insights
Paraneoplastic neurological diseases (PNDs) involve immune responses to onconeural antigens. This study details antigen spreading in small cell lung cancer (SCLC), revealing potential dissociation between anti-tumor and anti-neural immunity.
Area of Science:
- Neuroimmunology
- Oncology
Background:
- Paraneoplastic neurological diseases (PNDs) are characterized by immune responses targeting onconeural antigens.
- While IgG antibodies to single antigens are common, multiple antigen specificities are rare, often associated with specific cancers like small cell lung cancer (SCLC).
Observation:
- A case study of a 70-year-old male with PND and SCLC exhibiting onconeural antigen spreading.
- The patient displayed a broadening immune response against multiple onconeural antigens over time.
Findings:
- Onconeural antigen spreading in PND can be driven by tumor antigen expression changes due to mutagenic processes.
- A self-propagating immune response causing neuronal destruction can also lead to antigen spreading.
Implications:
- This phenomenon highlights potential mechanisms for the development of PNDs.
- It suggests a possible dissociation between the immune system's response to the tumor and its response to neural tissue during PND progression.
Related Concept Videos
Spreading of Chromatin Modifications
Writers
The writer...
Antigen Presenting Cells
T cells require the help of antigen-presenting cells (APCs), which process foreign antigens into smaller fragments that can be recognized by T cells. These APCs are highly specialized cells that efficiently internalize antigens...
Lung Capacity
EPS and iPS Cells in Disease Research
Cancer Cell Migration through Invadopodia
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...

